CL2018000420A1 - Nuevo derivado de catecol y composición farmacéutica que comprende el mismo. - Google Patents
Nuevo derivado de catecol y composición farmacéutica que comprende el mismo.Info
- Publication number
- CL2018000420A1 CL2018000420A1 CL2018000420A CL2018000420A CL2018000420A1 CL 2018000420 A1 CL2018000420 A1 CL 2018000420A1 CL 2018000420 A CL2018000420 A CL 2018000420A CL 2018000420 A CL2018000420 A CL 2018000420A CL 2018000420 A1 CL2018000420 A1 CL 2018000420A1
- Authority
- CL
- Chile
- Prior art keywords
- compuestos
- los
- preparacion
- tratar
- composicion
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/08—Hydrogen atoms or radicals containing only hydrogen and carbon atoms
- C07D333/10—Thiophene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150118247A KR102100470B1 (ko) | 2015-08-21 | 2015-08-21 | 신규한 카테콜 유도체 및 이를 포함하는 약학적 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2018000420A1 true CL2018000420A1 (es) | 2018-08-10 |
Family
ID=58100312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2018000420A CL2018000420A1 (es) | 2015-08-21 | 2018-02-15 | Nuevo derivado de catecol y composición farmacéutica que comprende el mismo. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10662169B2 (es) |
| EP (1) | EP3339299B1 (es) |
| JP (1) | JP6811234B2 (es) |
| KR (1) | KR102100470B1 (es) |
| CN (1) | CN107922374B (es) |
| AU (2) | AU2016312736A1 (es) |
| BR (1) | BR112018003313A2 (es) |
| CA (1) | CA2994377C (es) |
| CL (1) | CL2018000420A1 (es) |
| ES (1) | ES2865335T3 (es) |
| IL (1) | IL257621B (es) |
| MX (1) | MX2018002177A (es) |
| WO (1) | WO2017034242A2 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020022220A2 (pt) | 2018-06-01 | 2021-02-02 | Autophagysciences Inc. | novo composto e composição farmacêutica compreendendo o mesmo |
| AU2019304832A1 (en) * | 2018-07-20 | 2021-01-21 | Hexapharmatec Co., Ltd. | Novel catechol derivatives or salt thereof, processes for preparing the same, and pharmaceutical compositions comprising the same |
| KR20210130016A (ko) | 2020-04-21 | 2021-10-29 | (주)헥사파마텍 | 신규의 2-아릴티아졸 유도체 또는 이의 염, 이의 제조방법, 및 이를 함유하는 약학 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1355555A (en) * | 1919-10-22 | 1920-10-12 | Howk John Simeon | Spring-controller |
| DE3864248D1 (de) * | 1987-12-14 | 1991-09-19 | Sawai Seiyaku Kk | Carboxamide mit tetrazol- und thiazol-ringen und ihre anwendung. |
| WO2005030206A1 (en) * | 2003-09-24 | 2005-04-07 | Imclone Systems Incorporated | Aryl-1,3-azole derivatives and methods for inhibiting heparnase activity |
| US20050209284A1 (en) * | 2004-02-12 | 2005-09-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | Tec kinase inhibitors |
| WO2007035478A2 (en) * | 2005-09-20 | 2007-03-29 | Merck & Co., Inc. | Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| US9321730B2 (en) | 2007-08-21 | 2016-04-26 | The Hong Kong Polytechnic University | Method of making and administering quinoline derivatives as anti-cancer agents |
| KR101692047B1 (ko) * | 2010-11-30 | 2017-01-04 | 연세대학교 산학협력단 | 오토파지 관련 질환, 혈관신생질환 또는 멜라닌 관련 질환의 예방 또는 치료용 약제학적 조성물 |
| WO2012083866A1 (en) | 2010-12-22 | 2012-06-28 | The Hong Kong Polytechnic University | Quinoline derivatives as anti-cancer agents |
-
2015
- 2015-08-21 KR KR1020150118247A patent/KR102100470B1/ko active IP Right Grant
-
2016
- 2016-08-19 MX MX2018002177A patent/MX2018002177A/es unknown
- 2016-08-19 US US15/751,707 patent/US10662169B2/en active Active
- 2016-08-19 WO PCT/KR2016/009196 patent/WO2017034242A2/ko active Application Filing
- 2016-08-19 JP JP2018508206A patent/JP6811234B2/ja active Active
- 2016-08-19 BR BR112018003313-8A patent/BR112018003313A2/pt active Search and Examination
- 2016-08-19 ES ES16839531T patent/ES2865335T3/es active Active
- 2016-08-19 AU AU2016312736A patent/AU2016312736A1/en not_active Abandoned
- 2016-08-19 EP EP16839531.7A patent/EP3339299B1/en active Active
- 2016-08-19 CN CN201680046879.0A patent/CN107922374B/zh active Active
- 2016-08-19 CA CA2994377A patent/CA2994377C/en active Active
-
2018
- 2018-02-15 CL CL2018000420A patent/CL2018000420A1/es unknown
- 2018-02-19 IL IL257621A patent/IL257621B/en active IP Right Grant
-
2020
- 2020-03-27 US US16/833,280 patent/US20200255397A1/en not_active Abandoned
-
2021
- 2021-04-16 AU AU2021202309A patent/AU2021202309B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021202309B2 (en) | 2022-06-23 |
| JP2018529653A (ja) | 2018-10-11 |
| US20180244644A1 (en) | 2018-08-30 |
| CN107922374A (zh) | 2018-04-17 |
| EP3339299A2 (en) | 2018-06-27 |
| JP6811234B2 (ja) | 2021-01-13 |
| US10662169B2 (en) | 2020-05-26 |
| KR102100470B1 (ko) | 2020-04-13 |
| CA2994377C (en) | 2023-10-10 |
| CA2994377A1 (en) | 2017-03-02 |
| WO2017034242A3 (ko) | 2017-04-20 |
| MX2018002177A (es) | 2018-06-06 |
| ES2865335T3 (es) | 2021-10-15 |
| EP3339299B1 (en) | 2021-03-03 |
| KR20170022790A (ko) | 2017-03-02 |
| AU2021202309A1 (en) | 2021-05-13 |
| AU2021202309A2 (en) | 2021-07-22 |
| AU2016312736A1 (en) | 2018-03-08 |
| EP3339299A4 (en) | 2019-01-16 |
| BR112018003313A2 (pt) | 2018-09-18 |
| WO2017034242A2 (ko) | 2017-03-02 |
| IL257621A (en) | 2018-04-30 |
| US20200255397A1 (en) | 2020-08-13 |
| IL257621B (en) | 2021-02-28 |
| CN107922374B (zh) | 2020-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3241135A4 (en) | Code instrumentation for runtime application self-protection | |
| BR112016022868A2 (pt) | método para preparação de amg 416. | |
| EP3672766C0 (en) | DOUBLE BLADE LOCKING MECHANISM | |
| EP3556520A4 (en) | FIXED POINT MECHANISM | |
| CL2018001297A1 (es) | Proceso para preparar una formulación en polvo seco que comprende un anticolinérgico, un corticosteroide y un beta-adrenérgico | |
| EP3310989A4 (en) | Running tool lock mechanism | |
| ZA201902762B (en) | Mission-critical push-to-talk | |
| EP3306191A4 (en) | Combustor | |
| DK3386951T3 (en) | Phenylderivater som cannabinoidreceptor-2-agonister | |
| EP3246123A4 (en) | Wire-advancing mechanism | |
| DK3347360T3 (da) | Forbindelser, som er anvendelige til inhibering af ror-gamma-t | |
| EP3251865A4 (en) | Printer | |
| CL2018000420A1 (es) | Nuevo derivado de catecol y composición farmacéutica que comprende el mismo. | |
| EP3251864A4 (en) | Printer | |
| EP3363572A4 (en) | BLADE | |
| EP3299025A4 (en) | COMPOSITION WITH QUISQUALIS INDICA | |
| EP3339041A4 (en) | Printer | |
| EP3348409A4 (en) | PRINTER | |
| EP3320785A4 (en) | COMPOSITION CONTAINING ASPEROID DEDIPSACUS EXTRACTS | |
| EP3284605A4 (en) | Printer | |
| EP3272545A4 (en) | Printer | |
| EP3330052A4 (en) | HAND SAW | |
| ZA201807867B (en) | Radial parallel sawing | |
| GB2562338B (en) | Monoterpene phenol derivatives | |
| BR112017020050A2 (pt) | nova cor para bebidas. |